Efficacy and safety of nivolumab for advanced/recurrent non-small-cell lung cancer: an up-to-date meta-analysis of large-scale phase III randomized controlled trials PRISMA checklist - supplementary material

Name: Efficacy and safety of nivolumab for advanced/recurrent non-small-cell lung cancer: an up-to-date meta-analysis of large-scale phase III randomized controlled trials PRISMA checklist - supplementary material
Creator: Chen, Guo; Zhang, Hong; Zhang, Limin; Chen, Keling
Published: 2022-11-23T00:00:00+08:00

Taylor & Francis Group2024-05-15 更新2026-04-16 收录

非小细胞肺癌免疫治疗

临床效果Meta分析

数据链接：

https://tandf.figshare.com/articles/dataset/Efficacy_and_safety_of_nivolumab_for_advanced_recurrent_non-small-cell_lung_cancer_an_up-to-date_meta-analysis_of_large-scale_phase_III_randomized_controlled_trials_PRISMA_checklist_-_supplementary_material/21610611/1 数据链接链接失效反馈

官方服务：

资源简介：

Efficacy and safety of nivolumab for advanced/recurrent non-small-cell lung cancer: an up-to-date meta-analysis of large-scale phase III randomized controlled trials PRISMA checklist - supplementary material

提供机构：

Chen, Guo; Zhang, Hong; Zhang, Limin; Chen, Keling

创建时间：

2022-11-23